aTyr Pharma, Inc.
NASDAQ:LIFE
1.9 (USD) • At close June 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.353 | 10.386 | 0 | 10.455 | 0.422 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.741 | 1.695 | 1.304 | 17.291 | 14.048 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -2.388 | 8.691 | -1.304 | -6.836 | -13.626 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| -6.765 | 0.837 | 0 | -0.654 | -32.289 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 42.293 | 42.808 | 23.264 | 17.291 | 14.048 | 20.385 | 30.067 | 42.846 | 34.504 | 16.777 | 13.832 |
| General & Administrative Expenses
| 12.979 | 13.982 | 10.751 | 9.075 | 9.352 | 12.435 | 17.078 | 15.094 | 13.112 | 6.777 | 5.71 |
| Selling & Marketing Expenses
| -2.741 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.238 | 13.982 | 10.751 | 9.075 | 9.352 | 12.435 | 17.078 | 15.094 | 13.112 | 6.777 | 5.71 |
| Other Expenses
| 4.522 | 1.061 | 0.238 | -0.319 | -0.785 | -1.695 | -1.062 | 0 | -0.357 | 0 | 0 |
| Operating Expenses
| 52.531 | 56.79 | 34.015 | 26.366 | 23.4 | 32.82 | 47.145 | 57.94 | 47.616 | 23.554 | 19.542 |
| Operating Income
| -54.919 | -46.404 | -34.015 | -15.911 | -22.978 | -32.82 | -47.145 | -57.94 | -47.616 | -23.554 | -19.542 |
| Operating Income Ratio
| -155.578 | -4.468 | 0 | -1.522 | -54.45 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 4.522 | 1.061 | 0.238 | -0.319 | -0.785 | -1.695 | -1.062 | 0.036 | -0.357 | -0.796 | -0.472 |
| Income Before Tax
| -50.397 | -45.343 | -33.777 | -16.23 | -23.763 | -34.515 | -48.207 | -57.904 | -47.973 | -24.35 | -20.014 |
| Income Before Tax Ratio
| -142.768 | -4.366 | 0 | -1.552 | -56.31 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.008 | -1.066 | -1.313 | -1.272 | -1.526 | -1.695 | -0.713 | -0.049 | -0.869 | 0.796 | 0.472 |
| Net Income
| -50.389 | -44.277 | -32.464 | -14.958 | -22.237 | -34.515 | -48.207 | -57.855 | -47.973 | -24.35 | -20.014 |
| Net Income Ratio
| -142.745 | -4.263 | 0 | -1.431 | -52.694 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.94 | -1.56 | -1.7 | -1.63 | -6.63 | -16.13 | -26.13 | -34.2 | -42.4 | -33.84 | -27.82 |
| EPS Diluted
| -0.94 | -1.56 | -1.7 | -1.63 | -6.63 | -16.11 | -26.13 | -34.2 | -42.4 | -33.84 | -27.82 |
| EBITDA
| -52.178 | -46.404 | -34.015 | -15.911 | -22.978 | -32.82 | -47.145 | -57.911 | -47.616 | -22.761 | -18.8 |
| EBITDA Ratio
| -147.813 | -4.468 | 0 | -1.522 | -54.45 | 0 | 0 | 0 | 0 | 0 | 0 |